REG - Chrysalis Investment - Update on claim against Revolution Beauty Group

Chrysalis InvestmentsAnnouncement

02/01/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250102:nRSB8155Ra&default-theme=true

RNS Number : 8155R  Chrysalis Investments Limited  02 January 2025

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area (other than to professional
investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the
Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of
South Africa.

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014 which forms part of domestic law in the United Kingdom
pursuant to The European Union Withdrawal Act 2018, as amended by The Market
Abuse (Amendment) (EU Exit) Regulations 2019.

 

 

2 January 2025

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Update on claim against Revolution Beauty Group plc

 

Further to the announcement made on 22 April 2024, the Company can confirm
that it has now agreed and entered into a settlement agreement with Revolution
Beauty in full and final satisfaction of its claim. Under the terms of the
settlement, Revolution Beauty has agreed to pay the Company a non-material
sum, being less than 1% of the Company's market capitalisation (as at the date
of this announcement). All other details of the settlement remain
confidential.

 

 

-ENDS-

 

 For further information, please contact

 Media                                     +44 (0) 7921 881 800

 Montfort Communications:                  chrysalis@montfort.london

 Charlotte McMullen / Imogen Saunders

 Investment Adviser

 Chrysalis Investment Partners LLP:        +44 (0) 20 7871 5343

 James Simpson

 G10 Capital Limited (AIFM):               +44 (0) 20 7397 5450
 Maria Baldwin

 Panmure Liberum:                          +44 (0) 20 3100 2000

 Chris Clarke / Darren Vickers

 Deutsche Numis:                           +44 (0) 20 7260 1000

 Nathan Brown / Matt Goss

 IQEQ Fund Services (Guernsey) Limited:    +44 (0) 1481 231852

 Aimee Gontier / Elaine Smeja

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at
https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's
investments has been provided by the relevant underlying portfolio company and
has not been independently verified by the Company. The information contained
herein is unaudited.

This announcement is for information purposes only and is not an offer to
invest. All investments are subject to risk. Past performance is no guarantee
of future returns. Prospective investors are advised to seek expert legal,
financial, tax and other professional advice before making any investment
decision. The value of investments may fluctuate. Results achieved in the past
are no guarantee of future results. Neither the content of the Company's
website, nor the content on any website accessible from hyperlinks on its
website for any other website, is incorporated into, or forms part of, this
announcement nor, unless previously published by means of a recognised
information service, should any such content be relied upon in reaching a
decision as to whether or not to acquire, continue to hold, or dispose of,
securities in the Company.

The Company is an alternative investment fund ("AIF") for the purposes of the
AIFM Directive and as such is required to have an investment manager who is
duly authorised to undertake the role of an alternative investment fund
manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ
Group).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDEAPAFDSDLFFA